KREBSBIO — Krebs Biochemicals And Industries Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.90bn
- IN₹4.02bn
- IN₹433.12m
Annual cashflow statement for Krebs Biochemicals And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -284 | -445 | -247 | -197 | -269 |
| Depreciation | |||||
| Non-Cash Items | 65.5 | 51.1 | 32.6 | 51.2 | 57.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 21.1 | 159 | -98.4 | 101 | 66.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -146 | -172 | -247 | 23 | -78.9 |
| Capital Expenditures | -255 | -271 | -152 | -94.2 | -35.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 29.6 | 41.8 | 25.1 | 16 | -14.1 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -225 | -229 | -126 | -78.2 | -49.7 |
| Financing Cash Flow Items | -62.8 | -53.9 | -29.7 | -46.9 | -59.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 377 | 395 | 373 | 55.6 | 129 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.36 | -6.1 | -0.148 | 0.516 | 0.042 |